Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 26
Filter
1.
Intern Med ; 62(8): 1185-1189, 2023 Apr 15.
Article in English | MEDLINE | ID: mdl-36104195

ABSTRACT

Lacosamide is an antiepileptic drug that acts on voltage-gated sodium channels and was approved as an antiepileptic by the Food and Drug Administration in 2008. Although the efficacy and safety of lacosamide have been established in many previous trials, some case reports have shown that it may lead to cardiovascular side effects, especially in patients with electrical conduction system disorders. We herein report a case of life-threatening cardiac arrhythmia caused by lacosamide intoxication that was successfully treated with veno-arterial extracorporeal membrane oxygenation.


Subject(s)
Extracorporeal Membrane Oxygenation , Humans , Lacosamide , Anticonvulsants/therapeutic use , Tachycardia
2.
Rinsho Shinkeigaku ; 62(3): 184-189, 2022 Mar 29.
Article in Japanese | MEDLINE | ID: mdl-35228459

ABSTRACT

A 31-year-old man visited our hospital due to experiencing severe headaches, vomiting, and hypesthesia in the left side of his body. He had no past illnesses and had had no severe headaches before. The symptoms started the day after receiving the coronavirus disease 2019 (COVID-19) vaccination with Tozinameran. An MRI revealed cerebral venous sinus thrombosis and high intensity (DWI & FLAIR) of the right thalamus. Anticoagulant therapy was initiated, and his symptoms improved gradually. The follow-up MRI showed recanalization in a large part of the occluded venous sinuses. Most of the coagulation tests were normal, except for slightly high value of D-dimer, and the polymerase chain reaction (PCR) test for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was negative. Further cases are needed to judge if there is some sort of relationship between the vaccination and the cerebral venous sinus thrombosis.


Subject(s)
COVID-19 , Sinus Thrombosis, Intracranial , Adult , Humans , Magnetic Resonance Imaging , Male , SARS-CoV-2 , Sinus Thrombosis, Intracranial/diagnostic imaging , Sinus Thrombosis, Intracranial/etiology , Vaccination
3.
Rev Sci Instrum ; 89(4): 043105, 2018 Apr.
Article in English | MEDLINE | ID: mdl-29716374

ABSTRACT

We report details of an electron-ion coincidence apparatus, which has been developed for molecular-frame electron energy loss spectroscopy studies. The apparatus is mainly composed of a pulsed electron gun, an energy-dispersive electron spectrometer, and an ion momentum imaging spectrometer. Molecular-orientation dependence of the high-energy electron scattering cross section can be examined by conducting measurements of vector correlation between the momenta of the scattered electron and fragment ion. Background due to false coincidences is significantly reduced by introducing a pulsed electron beam and pulsing scheme of ion extraction. The experimental setup has been tested by measuring the inner-shell excitation of N2 at an incident electron energy of 1.5 keV and a scattering angle of 10.2°.

4.
Neurosurg Rev ; 41(2): 549-556, 2018 Apr.
Article in English | MEDLINE | ID: mdl-28815322

ABSTRACT

Headache is a major symptom in chronic subdural hematoma (CSDH) patients. However, some CSDH patients do not complain headache although the hematoma is thick with definite midline shift. This clinical study was performed to identify the mechanism of headache in CSDH patients. We compiled clinical data of 1080 surgically treated CSDH patients (711 males and 369 females), and in 54 cases, the pressure of hematoma was measured during burr hole surgery using a glass-stick manometer. Headache was recognized in 22.6% of patients, while nausea or vomit suggesting increased intracranial pressure was detected in only 3.0%. Ophthalmological examination was performed in 238 patients, and papilledema was identified in only one patient (0.4%). The mean age of patients with headache (59.8 ± 16.9 years) was significantly younger than that of those without (75.7 ± 11.2 years) (P < 0.01). In 54 cases, the mean hematoma pressure was not significantly different between patients with (17.1 ± 6.2 mmH2O) and without (18.4 ± 7.2 mmH2O) headache (P > 0.10). Hematoma thickness was significantly greater in patients without headache (P < 0.01), but the ratio of midline shift to hematoma thickness was significantly greater in patients with headache (P < 0.01). In our results, the status of increased intracranial pressure was rare in CSDH patients, and high hematoma pressure was not a cause of headache. Midline shift was the most influenced factor for headache in our study, and based on the results, the authors consider that the potential cause of headache in CSDH might be stretching or twisting of the pain-sensitive meninges and meningeal arteries or veins.


Subject(s)
Headache/epidemiology , Hematoma, Subdural, Chronic/complications , Adolescent , Adult , Aged , Aged, 80 and over , Female , Hematoma, Subdural, Chronic/pathology , Hematoma, Subdural, Chronic/physiopathology , Humans , Intracranial Pressure , Male , Middle Aged , Retrospective Studies , Risk Factors , Vomiting/epidemiology , Young Adult
5.
Phys Chem Chem Phys ; 20(2): 1063-1071, 2018 Jan 03.
Article in English | MEDLINE | ID: mdl-29236114

ABSTRACT

We report an (e, e+ion) spectroscopy study on electron-induced dissociative ionization of N2. Vector correlation between the scattered electron and N+ ion has been measured for inner-valence ionization of N2 at an incident electron energy of 1.4 keV and scattering angles of 2.2°, 4.2°, and 8.2°. By analyzing the experimental data, partial ion yield spectra have been obtained for transitions to the C 2Σ, F 2Σ, and 2σ ion states, showing that the individual transitions depend on the momentum transferred to the target, K, in different ways. The molecular-orientation dependence of the ionization cross section has subsequently been examined for the F 2Σ ionization. To account for the angular anisotropy of the scattering cross section, a compact analytical form has been developed. It is elucidated that for small K the F 2Σ ionization preferentially takes place when the molecule has its axis aligned parallel to the momentum transfer vector due to σu shape resonance, while the angular distribution drastically changes with K, indicating strong influences of non-dipole interaction on the ionization dynamics. It has been shown that the present method provides a powerful means to explore K-dependent stereodynamics in electron-induced dissociative ionization of molecules.

6.
NMC Case Rep J ; 3(3): 53-57, 2016 Jul.
Article in English | MEDLINE | ID: mdl-28663998

ABSTRACT

Lemierre syndrome (LS) is a rare life-threatening disease that is often caused by an acute oropharyngeal infection with a secondary thrombophlebitis of the internal jugular vein. LS rarely manifests as cranial nerve palsy. To the best of our knowledge, this is the second case report of LS associated with recurrent laryngeal nerve palsy. A 66-year-old female presented to a dental clinic with gingivitis and sore throat. Due to moderate periodontitis, her left first upper molar was extracted. A few days later, she subsequently developed a coarse voice and occipital headaches, and was referred to an otolaryngologist. She was diagnosed with left recurrent laryngeal nerve palsy and subsequent left-sided otitis media, and was referred to us for persistent headaches. She intermittently presented with high-grade fever and complained of salty taste disturbance. Her head magnetic resonance imaging (MRI) revealed left mastoiditis, thrombosis in the left transverse and sigmoid sinus, and left internal jugular vein. Her laboratory tests revealed an elevated white blood cell count, levels of C-reactive protein, and D-dimer. No endogenous coagulopathy was confirmed. Although, blood and cerebrospinal fluid culture grew no microorganisms, respectively, the empirically determined antibiotic therapy was initiated. In a week, the patient defervesced and had no headaches despite persistent thrombosis. Early diagnosis and an immediate antibiotic treatment are crucial for LS patients. Anticoagulation therapy was not needed for our patient and is still controversial for LS.

7.
Leuk Lymphoma ; 56(7): 2141-5, 2015 Jul.
Article in English | MEDLINE | ID: mdl-25347427

ABSTRACT

MYD88 and CD79B mutations that activate nuclear factor (NF)-κB signaling are prevalent in subsets of diffuse large B-cell lymphoma (DLBCL). We examined the prevalence of somatic mutations in the Toll/interleukin-1 receptor (TIR) domain of MYD88 and the tyrosine-based activation motif (ITAM) domain of CD79A/B in 18 primary central nervous system (CNS) DLBCLs, and their immunoprofile. MYD88 mutation was found in 17 cases (94.4%), all of which were L265P substitutions. CD79B mutation was found in 11 cases (61.1%), 10 (55.6%) of which were Y196C/D/H substitutions. Mutation of CD79A was completely absent. Immunohistochemically, all the tumors were CD3-/CD5-/CD20+/CD79a+/ GCET1-/BCL6+/MUM1+. Three (16.7%) cases were CD10+, but the majority (15 cases, 83.3%) were CD10-. Overall, all cases harbored either MYD88(L265P) or CD79B(Y196C/D/H), or both, irrespective of their immunoprofile. Our results suggest that CNS DLBCL is a group of tumors harboring a characteristic mutation profile which triggers NF-κB signaling in the immune-privileged site.


Subject(s)
CD79 Antigens/genetics , Central Nervous System Neoplasms/genetics , Lymphoma, Large B-Cell, Diffuse/genetics , Mutation/genetics , Myeloid Differentiation Factor 88/genetics , Adult , Aged , Aged, 80 and over , Central Nervous System Neoplasms/pathology , Female , Follow-Up Studies , Humans , Immunoenzyme Techniques , In Situ Hybridization , Lymphoma, Large B-Cell, Diffuse/pathology , Male , Middle Aged , Neoplasm Staging , Prevalence , Prognosis , Real-Time Polymerase Chain Reaction , Retrospective Studies
8.
BMC Neurol ; 14: 150, 2014 Jul 23.
Article in English | MEDLINE | ID: mdl-25056440

ABSTRACT

BACKGROUND: Osteogenesis imperfecta (OI) is a heterogeneous group of inherited disorders that occur owing to the abnormalities in type 1 collagen, and is characterized by increased bone fragility and other extraskeletal manifestations. We report the case of a patient who was diagnosed with OI following subarachnoid hemorrhage (SAH) secondary to a ruptured saccular intracranial aneurysm (IA). CASE PRESENTATION: A 37-year-old woman was referred to our hospital because of sudden headache and vomiting. She was diagnosed with SAH (World Federation of Neurosurgical Society grade 2) owing to an aneurysm of the middle cerebral artery. She then underwent surgical clipping of the aneurysm successfully. She had blue sclerae, a history of several fractures of the extremities, and a family history of bone fragility and blue sclerae in her son. According to these findings, she was diagnosed with OI type 1. We performed genetic analysis for a single nucleotide G/C polymorphism (SNP) of exon 28 of the gene encoding for alpha-2 polypeptide of collagen 1, which is a potential risk factor for IA. However, this SNP was not detected in this patient or in five normal control subjects. Other genetic analyses did not reveal any mutations of the COL1A1 or COL1A2 gene. The cerebrovascular system is less frequently involved in OI. OI is associated with increased vascular weakness owing to collagen deficiency in and around the blood vessels. SAH secondary to a ruptured IA with OI has been reported in only six cases. CONCLUSION: The patient followed a good clinical course after surgery. It remains controversial whether IAs are caused by OI or IAs are coincidentally complicated with OI.


Subject(s)
Intracranial Aneurysm/complications , Osteogenesis Imperfecta/complications , Subarachnoid Hemorrhage/complications , Adult , Aneurysm, Ruptured/complications , Female , Humans
9.
World J Surg Oncol ; 12: 123, 2014 Apr 26.
Article in English | MEDLINE | ID: mdl-24767145

ABSTRACT

Combined chemotherapy and prophylactic cranial irradiation has improved the prognosis of children with acute leukemia. However cranial irradiation carries a latent risk of the induction of secondary intracranial tumors. We encountered a patient who developed multiple intracranial radiation-induced meningiomas (RIMs) 25 years after prophylactic cranial irradiation for the treatment of acute leukemia in childhood. The patient had 3 intracranial lesions, 1 of which showed rapid growth within 6 months; another of the tumors also enlarged within a short period. All of the tumors were surgically treated, and immunohistochemistry indicated a high MIB-1 labeling index in each of the multiple lesions. In the literature, the MIB-1 labeling indices of 27 tumors from 21 patients were examined. Among them, 12 recurrent tumors showed higher MIB-1 labeling indices compared to the MIB-1 labeling indices of the non-recurrent tumors. Overall, 11 of the patients with RIM had multiple lesions and 8 cases developed recurrence (72.7%). RIM cases with multiple lesions had higher MIB-1 labeling indices compared to the MIB-1 labeling indices of cases with single lesions. Collectively, these data showed that the MIB-1 labeling index is as important for predicting RIM recurrences, as it is for predicting sporadic meningioma (SM) recurrences. RIMs should be treated more aggressively than SMs because of their greater malignant potential.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/adverse effects , Cranial Irradiation/adverse effects , Ki-67 Antigen/metabolism , Meningioma/etiology , Neoplasm Recurrence, Local/etiology , Neoplasms, Radiation-Induced/etiology , Precursor Cell Lymphoblastic Leukemia-Lymphoma/radiotherapy , Adult , Biomarkers, Tumor/metabolism , Combined Modality Therapy , Female , Humans , Immunoenzyme Techniques , Meningioma/metabolism , Meningioma/pathology , Neoplasm Recurrence, Local/metabolism , Neoplasm Recurrence, Local/pathology , Neoplasms, Radiation-Induced/metabolism , Neoplasms, Radiation-Induced/pathology , Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy , Precursor Cell Lymphoblastic Leukemia-Lymphoma/pathology , Prognosis
10.
Med Mol Morphol ; 47(1): 1-7, 2014 Mar.
Article in English | MEDLINE | ID: mdl-23955641

ABSTRACT

There have been several reports of temozolomide (TMZ) treatment of pituitary carcinomas and atypical adenomas. O(6)-methyl-guanine-DNA methyltransferase is not the sole molecule determining the sensitivity to TMZ in pituitary carcinomas and atypical adenomas. The Japan Society of Hypothalamic and Pituitary Tumors study suggests that MSH6, one of mismatch repair pathway enzyme, fulfills a contributory role to the efficacy of TMZ treatment for pituitary carcinomas and atypical adenomas. The preserved MSH6 function might be essential for the responsiveness to TMZ treatment in pituitary carcinomas and atypical adenomas.


Subject(s)
Adenoma/drug therapy , Biomarkers, Tumor/metabolism , Dacarbazine/analogs & derivatives , Pituitary Neoplasms/drug therapy , Adenoma/genetics , Adenoma/metabolism , Antineoplastic Agents, Alkylating/therapeutic use , Biomarkers, Tumor/genetics , DNA-Binding Proteins/genetics , DNA-Binding Proteins/metabolism , Dacarbazine/therapeutic use , Humans , O(6)-Methylguanine-DNA Methyltransferase/genetics , O(6)-Methylguanine-DNA Methyltransferase/metabolism , Pituitary Neoplasms/genetics , Pituitary Neoplasms/metabolism , Temozolomide , Treatment Outcome
11.
Acta Histochem Cytochem ; 46(5): 129-36, 2013 Oct 30.
Article in English | MEDLINE | ID: mdl-24194626

ABSTRACT

Skull base metastasis from differentiated thyroid carcinoma including follicular thyroid carcinoma (FTC) and papillary thyroid carcinoma (PTC) is a rare clinical entity. Eighteen FTC cases and 10 PTC cases showing skull base metastasis have been reported. The most common symptom of skull base metastasis from FTC and PTC is cranial nerve dysfunction. Bone destruction and local invasion to the surrounding soft tissues are common on radiological imaging. Skull base metastases can be the initial clinical presentation of FTC and PTC in the presence of silent primary sites. The possibility of skull base metastasis from FTC and PTC should be considered in patients with the clinical symptoms of cranial nerve dysfunction and radiological findings of bone destruction. A variety of genetic alterations in thyroid tumors have been identified to have a fundamental role in their tumorigenesis. Molecular histochemical studies are useful for elucidating the histopathological features of thyroid carcinoma. Recent molecular findings may provide novel molecular-based treatment strategies for thyroid carcinoma.

12.
J Med Case Rep ; 7: 116, 2013 Apr 26.
Article in English | MEDLINE | ID: mdl-23622107

ABSTRACT

INTRODUCTION: CyberKnife® radiation is an effective treatment for unresectable skull base tumors because it can deliver a highly conformational dose distribution to the complex shapes of tumor extensions. There have been few reports of severe complications with this treatment. This is the first published case report to our knowledge of cerebrospinal fluid leakage induced by CyberKnife® radiotherapy. CASE PRESENTATION: A skull base tumor was identified on magnetic resonance imaging in a 78-year-old Asian woman with a headache in her forehead. An endoscopic transnasal tumor resection was performed; however, the tumor, invading into the cavernous sinuses and optic canal, was not completely removed. During the subtotal resection of the tumor, no cerebrospinal fluid leakage was observed. Osteosarcoma was histologically diagnosed, and CyberKnife® radiation was performed to the residual tumor considering the aggressive feature of the tumor with a molecular immunology Borstel-1 index of 15%. Five months after the treatment, magnetic resonance imaging showed definite tumor shrinkage, and the patient had been living her daily life without any troubles. After another month, the patient was transferred to our clinic because of coma with high fever, and computed tomography demonstrated severe pneumocephalus. Rhinorrhea was definitely identified on admission; therefore, emergency repair of the cerebrospinal fluid leakage was performed using an endoscope. Dural defects at the bottom of the sella turcica were identified under careful endoscopic observation and fat tissue was patched to the dural defects. Follow-up computed tomography proved complete disappearance of air from the cisterns 2 weeks after the surgery, and the patient was discharged from our hospital without any neurological deficits. CONCLUSION: CyberKnife® radiation is one of the effective treatments for skull base tumors; however, the risk of cerebrospinal fluid leakage should be considered when tumor invasion to the dura mater is suspected. Emergency surgical treatment is required when cerebrospinal fluid leakage is induced by the radiotherapy because the leakage is not expected to be healed by palliative treatments.

13.
Endocr J ; 60(3): 369-73, 2013.
Article in English | MEDLINE | ID: mdl-23197045

ABSTRACT

Adult growth hormone (GH) deficiency (AGHD) in Japan is diagnosed based on peak GH concentrations during GH provocative tests such as GHRP-2 stimulation test. In this study, we aimed to evaluate the ability of serum insulin-like growth factor-1 (sIGF-1) and urinary GH (uGH) at the time of awakening to diagnose AGHD. Fifty-nine patients with pituitary disease (32 men and 27 women; age 20-85 y (57.5 ± 15.5, mean ± SD) underwent GHRP-2 stimulation and sIGF-1 testing. Thirty-six and 23 patients were diagnosed with and without severe AGHD, respectively based on a peak GH response of <9 ng/mL to GHRP-2 stimulation. Serum IGF-1 was evaluated as a standard deviation score (IGF-1 SDS) based on age and sex. We determined whether uGH levels in urine samples from 42 of the 59 patients at awakening were above or below the sensitivity limit. We evaluated IGF-1 SDS and uGH levels in a control group of 15 healthy volunteers. Values for IGF-1 SDS were significantly lower in patients with, than without (-2.07 ± 1.77 vs.-0.03 ± 0.92, mean ± SD; p < 0.001) AGHD whereas the range of IGF-1 SDS substantially overlapped at > -1.4. IGF-1 SDS discriminated AGHD more effectively in patients aged ≤60 years. The χ2 test revealed a statistical relationship between uGH and AGHD (test statistic: 7.0104 ≥ χ2 (1; 0.01) = 6.6349). When IGF-1 SDS is < -1.4 or uGH is below the sensitivity limit, AGHD can be detected with high sensitivity.


Subject(s)
Human Growth Hormone/deficiency , Human Growth Hormone/urine , Insulin-Like Growth Factor I/analysis , Adult , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Oligopeptides , Pituitary Diseases/complications
14.
Case Rep Neurol Med ; 2012: 891847, 2012.
Article in English | MEDLINE | ID: mdl-23119196

ABSTRACT

The presence of an intracranial aneurysm together with a pituitary adenoma presents tremendous risk of subarachnoid hemorrhage, during transsphenoidal surgery, particularly when the aneurysm lies near the operative field. A left supraclinoid internal carotid artery aneurysm and a clinically nonfunctioning pituitary adenoma coexisted in a 57-year-old woman. Initially, the aneurysm was treated by endovascular coil placement, and then the patient underwent pseudocapsule-based extracapsular resection of the pituitary tumor via a transnasal transsphenoidal endoscopic approach. Pseudocapsule-based extracapsular total resection was safely performed, because of the extirpated risk of rupture of the coil-treated aneurysm. Recently, transsphenoidal pseudocapsule-based extracapsular resection approach for pituitary adenomas provides a more effective and safe alternative compared to the traditional intracapsular one because of its higher tumor removal and remission rates and lower recurrence rate. Compared with conventional subcapsular removal, pseudocapsule-based extracapsular resection has more risks of aneurysmal rupture that is located adjacent to pituitary adenoma. Thus, in a patient having a cerebral aneurysm with the proximity to the operative field, the cerebral aneurysm should be first treated with endovascular coil placement or direct surgical procedure; subsequently, pseudocapsule-based extracapsular resection of the pituitary tumor via a transnasal transsphenoidal endoscopic approach should be performed.

15.
Radiat Oncol ; 7: 136, 2012 Aug 10.
Article in English | MEDLINE | ID: mdl-22883312

ABSTRACT

A review of patients with skull base osteosarcoma secondary to radiation (radiation-induced osteosarcoma: RIOS) of the pituitary tumor shows the mean survival of approximately 7 months (2 weeks-16 months). This warning prognosis seems to stem from two factors, 1) the anatomical complexity of the skull base for total resection of the tumor, and 2) standard adjuvant therapies for the tumor yet to be established. Contrary to the general belief, the authors report an unusually long survival of a 75-year-old woman with a history of osteosarcoma that developed in the same sequence 20 years after pituitary tumor radiation. On her recent admission, she complained of frontal headaches and MRI studies showed a tumor in the sphenoid sinus. Endoscopic trans-nasal tumor removal allowed for histological diagnosis of an osteosarcoma. However, further rapid tumor growth necessitated a radical tumor resection followed by a combined chemotherapy with ifosfamide, cisplatin, and etoposide (ICE). Despite temporary suppression of the tumor growth, the chemotherapy was discontinued due to severe pancytopenia that occurred after three courses of treatment. Shortly after the discontinuation of ICE therapy, the tumor size increased again rapidly, requiring a novel radiation therapy, Cyber-knife treatment. Following this radiation, the tumor growth was arrested, and the patient remains healthy without neurological symptoms over 24 months. The outcome of Cyber-knife in this case suggests that this specific therapy must be considered for the unresectable skull base RIOS.


Subject(s)
Bone Neoplasms/therapy , Neoplasm, Residual/therapy , Neoplasms, Radiation-Induced/therapy , Osteosarcoma/therapy , Skull Base Neoplasms/radiotherapy , Aged , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Bone Neoplasms/etiology , Bone Neoplasms/pathology , Cisplatin/administration & dosage , Combined Modality Therapy , Etoposide/administration & dosage , Female , Humans , Ifosfamide/administration & dosage , Magnetic Resonance Imaging , Neoplasm Staging , Neoplasm, Residual/etiology , Neoplasm, Residual/pathology , Neoplasms, Radiation-Induced/etiology , Neoplasms, Radiation-Induced/pathology , Osteosarcoma/etiology , Osteosarcoma/pathology , Prognosis , Skull Base Neoplasms/complications , Skull Base Neoplasms/surgery
16.
J Med Case Rep ; 6: 104, 2012 Apr 06.
Article in English | MEDLINE | ID: mdl-22483341

ABSTRACT

INTRODUCTION: Tumefactive multiple sclerosis is a demyelinating disease that demonstrates tumor-like features on magnetic resonance imaging. Although diagnostic challenges without biopsy have been tried by employing radiological studies and cerebrospinal fluid examinations, histological investigation is still necessary for certain diagnosis in some complicated cases. CASE PRESENTATION: A 37-year-old Asian man complaining of mild left leg motor weakness visited our clinic. Magnetic resonance imaging demonstrated high-signal lesions in bilateral occipital forceps majors, the left caudate head, and the left semicentral ovale on fluid-attenuated inversion recovery and T2-weighted imaging, and these lesions were enhanced by gadolinium-dimeglumin. Tumefactive multiple sclerosis was suspected because the enhancement indistinctly extended along the corpus callosum on magnetic resonance imaging and scintigraphy showed a low malignancy of the lesions. But oligoclonal bands were not detected in cerebrospinal fluid. In a few days, his symptoms fulminantly deteriorated with mental confusion and left hemiparesis, and steroid pulse therapy was performed. In spite of the treatment, follow-up magnetic resonance imaging showed enlargement of the lesions. Therefore, emergent biopsy was performed and finally led to the diagnosis of demyelinating disease. The enhanced lesion on magnetic resonance imaging disappeared after one month of prednisolone treatment, but mild disorientation and left hemiparesis remained as sequelae. CONCLUSIONS: Fulminant aggravation of the disease can cause irreversible neurological deficits. Thus, an early decision to perform a biopsy is necessary for exact diagnosis and appropriate treatment if radiological studies and cerebrospinal fluid examinations cannot rule out the possibility of brain tumors.

17.
Clin Neurol Neurosurg ; 114(6): 622-6, 2012 Jul.
Article in English | MEDLINE | ID: mdl-22244253

ABSTRACT

OBJECTIVE: For long-term preservation of ventriculo-peritoneal (VP) shunt function, it is essential to place the ventricular catheter tip above the foramen of Monro. But the free-hand technique for ventricular catheter passage is not consistent. METHODS: Supposing that a convex of skull matches to a sphere, in which the foramen of Monro is the center, a perpendicular direction from the surface of the sphere to inside always directs toward the center. The authors identified the range of skull where corresponded to the sphere by magnetic resonance imaging assessment and utilized tripod to achieve exactly perpendicular insertion of ventricular catheter. And an optimal length of catheter insertion was investigated by navigation system. RESULTS: The anterior-posterior range of the spherical portion was from coronal suture to 20mm anterior, and the lateral range of it was between 15 and 35mm lateral from sagittal suture. The optimal catheter length for insertion was between 55 and 58mm from the brain surface. Ideal placement of a ventricular catheter tip was achieved in more than 90% of cases (31/34) with this technique. CONCLUSION: Tripod-guided ventricular catheter insertion is a simple and reliable method for VP shunt at any angle of head-rotation.


Subject(s)
Catheterization/instrumentation , Catheterization/methods , Cerebral Ventricles/surgery , Adolescent , Adult , Aged , Brain/anatomy & histology , Brain Neoplasms/complications , Brain Neoplasms/surgery , Cerebral Ventricles/anatomy & histology , Cerebrospinal Fluid Shunts , Female , Humans , Hydrocephalus/surgery , Lymphoma/complications , Lymphoma/surgery , Magnetic Resonance Imaging , Male , Middle Aged , Neuronavigation/instrumentation , Reproducibility of Results , Surgery, Computer-Assisted , Treatment Outcome , Ventriculoperitoneal Shunt
18.
Med Mol Morphol ; 44(2): 63-70, 2011 Jun.
Article in English | MEDLINE | ID: mdl-21717308

ABSTRACT

Combined in situ hybridization (ISH) and immunohistochemistry (IHC) under electron microscopy (EM-ISH & IHC) has sufficient ultrastructural resolution to provide two-dimensional images of subcellular localization of pituitary hormone and its mRNA in a pituitary cell. The advantages of semiconductor nanocrystals (Quantum dots; Qdots) and confocal laser scanning microscopy (CLSM) enable us to obtain three-dimensional images of the subcellular localization of pituitary hormone and its mRNA. Both EM-ISH & IHC and ISH & IHC using Qdots and CLSM are useful for understanding the relationship between protein and mRNA simultaneously in two or three dimensions. CLSM observation of rab3B and SNARE proteins such as SNAP-25 and syntaxin revealed that both rab3B and SNARE system proteins play an important role and work together as the exocytotic machinery in anterior pituitary cells. Another important issue is the intracellular transport and secretion of pituitary hormone. An experimental pituitary cell line, the GH3 cell, in which growth hormone (GH) is linked to enhanced yellow fluorescein protein (EYFP), has been developed. This stable GH3 cell secretes GH linked to EYFP upon being stimulated by Ca(2+) influx or Ca(2+) release from storage. This GH3 cell is useful for real-time visualization of the intracellular transport and secretion of GH. These three methods enable us to visualize consecutively the processes of transcription, translation, transport, and secretion of pituitary hormone.


Subject(s)
Growth Hormone , Imaging, Three-Dimensional/methods , Qa-SNARE Proteins , RNA, Messenger/metabolism , Synaptosomal-Associated Protein 25 , rab3 GTP-Binding Proteins , Animals , Bacterial Proteins , Biological Transport/physiology , Cell Line , Exocytosis/physiology , Growth Hormone/metabolism , Humans , Immunohistochemistry/methods , In Situ Hybridization/methods , Luminescent Proteins , Microscopy, Confocal/methods , Microscopy, Electron/methods , Pituitary Gland/metabolism , Pituitary Gland/ultrastructure , Qa-SNARE Proteins/metabolism , Qa-SNARE Proteins/ultrastructure , Quantum Dots , Rats , Synaptosomal-Associated Protein 25/metabolism , Synaptosomal-Associated Protein 25/ultrastructure , rab3 GTP-Binding Proteins/metabolism , rab3 GTP-Binding Proteins/ultrastructure
19.
Surg Oncol ; 20(4): e127-31, 2011 Dec.
Article in English | MEDLINE | ID: mdl-21616660

ABSTRACT

Brain metastasis from uterine leiomyosarcoma is extremely rare, and prognostically alarming despite various treatments. The authors report a case of multiple brain metastases from uterine leiomyosarcoma who took a favorable course after tumor resection and γ-knife treatment. A 50-year-old woman with a history of hysterectomy for uterine leiomyosarcoma two years earlier, presented with a recent onset of headaches and vomiting. Multiple cerebral lesions were found by magnetic resonance imaging (MRI). The Karnofsky performance scale (KPS) was 40 with left hemiparesis and cerebellar ataxia. She was treated by resection of the left occipital and cerebellar tumors, followed by γ-knife irradiation of the residual tumors. KPS was 70 at her discharge from the hospital. MRI failed to show recurrence of the intracranial lesions 6 months after irradiation. She remained at home until she died from massive intra-abdominal bleeding. This is the first case with multiple brain metastases from uterine leiomyosarcoma, who survived with remarkable neurological improvement for 12 months. No comparable survival has been reported in the literature. It is evident that surgical resection and additional γ-knife irradiation contributed to early neurological recovery.


Subject(s)
Brain Neoplasms/surgery , Hysterectomy , Leiomyosarcoma/surgery , Radiosurgery , Uterine Neoplasms/surgery , Adult , Brain Neoplasms/secondary , Combined Modality Therapy , Female , Humans , Leiomyosarcoma/pathology , Magnetic Resonance Imaging , Review Literature as Topic , Uterine Neoplasms/pathology
20.
Molecules ; 16(5): 3618-35, 2011 Apr 29.
Article in English | MEDLINE | ID: mdl-21540793

ABSTRACT

In situ hybridization (ISH) at the electron microscopic (EM) level is essential for elucidating the intracellular distribution and role of mRNA in protein synthesis. EM-ISH is considered to be an important tool for clarifying the intracellular localization of mRNA and the exact site of pituitary hormone synthesis on the rough endoplasmic reticulum. A combined ISH and immunohistochemistry (IHC) under EM (EM-ISH&IHC) approach has sufficient ultrastructural resolution, and provides two-dimensional images of the subcellular localization of pituitary hormone and its mRNA in a pituitary cell. The advantages of semiconductor nanocrystals (quantum dots, Qdots) and confocal laser scanning microscopy (CLSM) enable us to obtain three-dimensional images of the subcellular localization of pituitary hormone and its mRNA. Both EM-ISH&IHC and ISH & IHC using Qdots and CLSM are useful for understanding the relationships between protein and mRNA simultaneously in two or three dimensions. CLSM observation of rab3B and SNARE proteins such as SNAP-25 and syntaxin has revealed that both rab3B and SNARE system proteins play important roles and work together as the exocytotic machinery in anterior pituitary cells. Another important issue is the intracellular transport and secretion of pituitary hormone. We have developed an experimental pituitary cell line, GH3 cell, which has growth hormone (GH) linked to enhanced yellow fluorescein protein (EYFP). This stable GH3 cell secretes GH linked to EYFP upon stimulation by Ca²+ influx or Ca²+ release from storage. This GH3 cell line is useful for the real-time visualization of the intracellular transport and secretion of GH. These three methods from conventional immunohistochemistry and fluorescein imaging allow us to consecutively visualize the process of transcription, translation, transport and secretion of anterior pituitary hormone.


Subject(s)
Immunohistochemistry/methods , Pituitary Gland/cytology , Pituitary Gland/metabolism , Animals , Growth Hormone/genetics , Growth Hormone/metabolism , Humans , In Situ Hybridization/methods , Microscopy, Electron
SELECTION OF CITATIONS
SEARCH DETAIL
...